conference reporter

63rd ASH Annual Meeting and Exposition

Conference Reporter in Chronic Lymphocytic Leukemia to Cover Key Topics Being Presented at the 63rd ASH Annual Meeting and Exposition

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. This issue of Conference Reporter will feature coverage of selected topics in Chronic Lymphocytic Leukemia presented at this year’s ASH Annual Meeting.

The clinicians who were surveyed selected the following expert commentators and topics from the upcoming conference.

Community-Selected Expert Commentators:

Jan A. Burger, MD, PhD

Professor, Tenured, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX

Matthew S. Davids, MD, MMSc

Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
Boston, MA

Anthony R. Mato, MD, MSCE

Director, Chronic Lymphocytic Leukemia Program
Associate Attending, Memorial Sloan Kettering Cancer Center
New York, NY


Community-Selected Topics: 

    Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia
    Taking a "Whole Patient" Approach to Treating Chronic Lymphocytic Leukemia
    Data on Investigational Novel-Novel Combinations for Chronic Lymphocytic Leukemia
    Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia
    Chronic Lymphocytic Leukemia: Real-World Data on Testing and Treatment
    Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents


This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Hematology.

More in CLL

Thumb

CLL

Long-term Survival Data With Preferred Frontline Therapies for Chronic Lymphocytic Leukemia

Conference Reporter by Jan A. Burger, MD, PhD

At the 63rd ASH Annual Meeting and Exposition, updated long-term data were reported from several trials of preferred frontline therapies for chroni...READ MORE

Thumb

CLL

Chronic Lymphocytic Leukemia Treatment Patterns in the Era of Novel Agents

Conference Reporter by Jan A. Burger, MD, PhD

First-line treatment for chronic lymphocytic leukemia (CLL) was the focus of several presentations at the 63rd ASH Annual Meeting and Exposition. O...READ MORE

Thumb

CLL

Extending Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia

Conference Reporter by Matthew S. Davids, MD, MMSc

Long-term data reported at the 63rd ASH Annual Meeting and Exposition reflected advancements in chronic lymphocytic leukemia (CLL), such as improve...READ MORE

More In Conference Reporter